Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C13H16N4O6.ClH |
| Molecular Weight | 360.75 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.[O-][N+](=O)C1=CC=C(O1)\C=N\N2C[C@H](CN3CCOCC3)OC2=O
InChI
InChIKey=PPSVFZXMDMUIGB-GSFIMPMYSA-N
InChI=1S/C13H16N4O6.ClH/c18-13-16(14-7-10-1-2-12(22-10)17(19)20)9-11(23-13)8-15-3-5-21-6-4-15;/h1-2,7,11H,3-6,8-9H2;1H/b14-7+;/t11-;/m0./s1
Levofuraltadone is the nitrofurane used for the treatment of trypanosomiasis. It has been shown to be effective in mice and polyneuritis, a serious side effect of nitrofurazone therapy, is less frequent with levofuraltadone. Nevertheless, levofuraltadone is a very toxic agent and it has never been commercially produced.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ZIA9BC2JJR
Created by
admin on Mon Mar 31 17:49:19 GMT 2025 , Edited by admin on Mon Mar 31 17:49:19 GMT 2025
|
PRIMARY | |||
|
13146-28-6
Created by
admin on Mon Mar 31 17:49:19 GMT 2025 , Edited by admin on Mon Mar 31 17:49:19 GMT 2025
|
PRIMARY | |||
|
7487-80-1
Created by
admin on Mon Mar 31 17:49:19 GMT 2025 , Edited by admin on Mon Mar 31 17:49:19 GMT 2025
|
SUPERSEDED | |||
|
9595286
Created by
admin on Mon Mar 31 17:49:19 GMT 2025 , Edited by admin on Mon Mar 31 17:49:19 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
